市場調査報告書：インドの製薬業界

Abstract

Market Intelligence Report

The complete report provides an invaluable mix of vital market data and background information, including five-year market projections. The report comprises four main sections: Pharmaceutical Market Outlook, Background Data, Healthcare System, and Accessing the Pharmaceutical Market. Report sections are dynamically updated, being re-issued when market developments demand it.

Pharmaceutical Market Outlook

An integral part of the full report, the Pharmaceutical Market Outlook, which includes five-year market projections, is also available separately.

The Indian pharmaceutical market is about to enter a new era, with the recognition under the TRIPs (Trade-Related aspects of Intellectual Property Rights) agreement of pharmaceutical product patents from 1st January 2005. This change undoubtedly makes the market a more attractive proposition to international companies, although entry into a market traditionally served by a vast, albeit fragmented domestic industry is likely to be extremely competitive. The market leaders are the big domestic firms: Ranbaxy, Dr. Reddy's and Cipla, among others, although no one company has a market share of more than 5%. In 2004, there are only three multinationals with a significant presence on the Indian market: GSK, Pfizer and Aventis.

As the Indian economy develops, more people move into the growing middle classes and gain disposable income. Alongside this is an increasing demand for high quality healthcare. Espicom's Market Intelligence Report sets the pharmaceutical market into context, providing background information on the country, its people and the organisation of its healthcare services, including information on the main private healthcare providers.

Inside the India Market Intelligence Report

Key information is provided on the regulatory environment, including the pharmaceutical policy, pharmaceutical registration, advertising, pharmaceutical patent protection and exclusive marketing right, and pricing regulation;
Distribution channels, trade fairs, pharmaceutical import data for 45 categories for 1998-2002;
Domestic production, including data on global sales by leading domestic companies for 2003/04 and a review of the trade associations and leading producers. Information is included on these domestic manufacturers: Alembic, Aurobindo Pharma, BCG Vaccine Laboratory, Biocon, Blue Cross Laboratories Cipla, Dr Reddy's, Lupin, Nicholas Piramal, Orchid, Ranbaxy, Sun Pharma, WocKhardt and Zydus Cadila as well as the Indian operations of Aventis Pharma, GlaxoSmithKline and Pfizer;
The current size of the market, five year market projections to 2009, the market outlook, the structure of the pharmaceutical market and recent market developments, such as the domestic companies involved with the WHO prequalification list for antiretroviral drugs;
Research and development, Traditional Indian medicines, pharmaceutical exports, contact information for government healthcare organisations and trade association;
Political and economic overviews;
Key data on the population, demographic indicators, mortality data, trends in morbidity and a review of the government's major health projects;
Information on India's healthcare infrastructure, including hospitals and ambulatory care, medical personnel and health expenditure.

EXECUTIVE SUMMARY
PHARMACEUTICAL MARKET
- Current Size
- Projections
- Outlook
- Market Structure
  - Domestic production
  - Multinationals
  - Trade Associations
  - Imports
  - Research & Development
  - Traditional Indian Medicines
- Market developments
  - Government Task Force on Drug Pricing
  - Easier Pharmaceutical Exports to Russ 13
  - Cipla at the Centre of Global Tamiflu Patent Debate
  - The Patents (Amendments) Bill, 2005
    - Compulsory Licensing
    - Pre- & Post-Grant Opposition
    - Mailbox Applications
    - Other Issues
  - Previous Patents Act Amendments and Exclusive Marketing Rights
    - Glivec/Gleevec Patent Setback for Novartis
    - Antiretrovirals and the WHO Prequalification List
  - National Pharmaceuticals Policy 2006
  - KEY NATIONAL DATA PROJECTIONS
Methodology and Sources
Trade Code Classifications
List of Tables
- Summary of the Indian Pharmaceutical Market in 2005
- Projected Pharmaceutical Market, 2005-2010
- SWOT Analysis of the Indian Pharmaceutical Market
- Analysis of India's Health Sector
- Global Sales by Leading Domestic Companies, 2004/05
- Pharmaceutical Imports, 1999-2003 (US$000s)
- Leading Suppliers, 2003 (US$000s)
- Key Data Projections, 2005-2010
List of Figures
- Radar Graph of India's Healthcare System
- Pharmaceutical Imports, Exports & Balance of Trade, 1998-2003 (US$000s)
- Pharmaceutical Imports by Type, 2003 (%)
GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
POPULATION.
- Population by States and Territories, 1991-2001
DEMOGRAPHIC IN 5
- Demographic Indicators, 1991-2001
- Estimated Birth and Death Rates by State, 2001
MORTALITY
- Major Causes of Death, Rural India 1993-1998
- Deaths from Non-Communicable Diseases, 1998
MORBIDITY
- National Rural Health Mission
- Child Survival and Safe Motherhood
  - Reproductive and Child Health Programme
  - Woman & Child Development project
  - Universal Immunisation Programme
    - Reported Incidence of Vaccine Preventable Diseases, 1985-2000
  - Reducing Fertility
    - Family Planning
    - All India Hospitals Post-Partum Programme
- National Health Programmes for Disease Control/Eradication
  - National Anti-Malaria Programme
    - Reported Malaria Incidence & Deaths, 1990-2001
  - National Filaria Control Programme
  - Kala-azar Control Programme
    - Reported Kala-azar Cases & Deaths, 1996-2002
  - National Programme for the Control of Blindn
  - National Leprosy Eradication Programme
  - National Tuberculosis Control Programme
  - HIV/AIDS
    - National AIDS Control Programme31H18
  - Japanese Encephalitis
  - Cancer
CHARTS
- Map of India
- Population by Age Group, 2001 (%).
ORGANISATION & ADMINISTRATION
- The Department of Health
- The Department of Family Welfare
- The Department of Indian Systems of Medicine & Homeopathy
- Health Insurance
  - Apollo Family Health Plan
HEALTH EXPENDITURE
- Central Sector Health Expenditure by Scheme, 1998/98 - 2001/02
HOSPITAL SERVICES
- Hospital Resources
  - Hospitals & Beds by State & Sector, 2
- Hospitals, Dispensaries & Beds, 1991-1998
  - Beds in Selected Hospitals, 2001/02
- All India Institute of Medical Sciences (AIIMS)
  - AIIMS Hospital Beds, 1999/2000
  - AIIMS Hospital Beds by Specialty, 1999/2000
  - AIIMS Hospital Activity, 1999/2000
- Safdarjung Hospital, New Delhi
  - Safdarjung Hospital Beds by Specialty, 2003
- Dr. Ram Manohar Lohia Hospital, New Delhi
  - Dr. Ram Manohar Lohia Hospital Beds by Specialty, 2000/01
- JIPMER Hospital, Pondicherry. 21H14
  - JIPMER Hospital Beds by Specialty, 2000
- PGIMER Nehru Hospital,
  - PGIMER Nehru Hospital Beds by Specialty, 2001/02
- Lady Hardinge Medical College Associated Hospitals, New Delhi
Private Hospitals and Clinics
- Apollo Hospitals Group
- Fortis Healthcare
- Max India
- Other Commercial Providers
AMBULATORY CARE
- Partial Infrastructure in the States/Union Territories Funded Under the Family Welfare Programme, 1994-1996
- CGHS Out-patient Facilities, 31st May 2003
First Aid and Disaster Relief
- St. John Ambulance
- Indian Red Cross Society
- Healthcare for the Underprivileged, Scheduled Castes and Scheduled Tribes
  - Healthcare Infrastructure in Tribal/Scheduled Caste Areas, 1995-2001
- Medical Care for Remote & Marginalised Tribal & Nomadic Communities
MEDICAL PERSONNEL .40
- Doctors Registered with State Medical Councils, 1991-2002
- Registered Nursing Personnel, 1991-1998
- Healthcare Personnel in Rural Areas, 1991 - 1998
- Training Centres Funded under the Family Welfare Programme, 1994-1998
INTRODUCTION
REGULATORY E NVIRONMENT
- National Pharmaceuticals Policy 2006
- Pharmaceutical Registration
- Advertising
- Patent Protection & Intellectual Property Rights
  - The Patents (Amendments) Bill, 2005
    - Compulsory Licensing
    - Pre- & Post-Grant Opposition
    - Mailbox Applications
    - Other Issues
  - Previous Patents Act Amendments and Exclusive Marketing Rights
    - Glivec/Gleevec Patent Setback for Novartis
- Pricing
  - Recent developments
DISTRIBUTION CHANNELS
- Medical Stores Organisation
TRADE FAIRS
- Hospimedica India
- India Pharma 2006
- Pharmaceutical Expo 2005
PHARMACEUTICAL IMPORTS
- Summary Pharmaceutical Imports, 1998-2003 (US$000s)
- Leading Pharmaceutical Suppliers, 2003 (US$000s)
Raw Material Imports
- Leading Suppliers of Raw Materials, 2003
Finished Medicament Imports
- Leading Suppliers of Finished Medicaments, 2003
- Imports of Pharmaceuticals, 1999-2003 (US$000s)
- Leading Suppliers, 2003 (US$000s)
- Leading Suppliers by Category, 2003 (US$000s)
DOMESTIC PRODUCTION .
- Global Sales by Leading Domestic Companies, 2004/05
BCG Vaccine Laboratory, Chennai (Madras)
Trade Associations
Domestic Producers
- Alembic Ltd
- Alembic Financial Results, 2003-2005
Aurobindo Pharma
- Aurobindo Pharma's ANDA Approvals, 2004-2005
- Aurobindo Pharma Financial Results, 2003-2005
Biocon
- Biocon Financial Results, 2003-2005
Blue Cross Laboratories Ltd
Cipla Ltd
- Cipla Financial Results, 2003-2005
Dr. Reddy's Laboratories Ltd
- Dr Reddy's Laboratories ANDA approvals, 2002-2005
- Dr Reddy's Financial Summary, 2003-2005
Lupin Limited
- Lupin's ANDA approvals, 2003-2005
- Lupin Financial Results, 2003-2005
Natco Pharma
- Natco Pharma Financial Results, 2003-2005
Nicholas Piramal India Ltd
- NPIL Financial Results, 2003-2005
Orchid Chemicals & Pharmaceuticals Ltd
- Orchid's Top-10 Brands
- Orchid's ANDA Approvals, 2005-2006
- Orchid Financial Results, 2003-2005
Ranbaxy Laboratories Ltd
- Ranbaxy's Top 10 Products
- Ranbaxy Laboratories ANDA approvals 2002-2005
- Ranbaxy Financial Results, 2003-2005
Sun Pharmaceutical Industries Ltd
- Sun Pharma Financial Results, 2003-2005
Wockhardt Ltd
- Wockhardt's ANDA Approvals, 2003-2005
- Wockhardt Financial Results, 2003-2004
Zydus Cadila
- Zydus' ANDA Approvals, 2005
- Zydus Cadila Financial Results, 2003-2005
Multinational Activity
Aventis Pharma India
GlaxoSmithKline
Pfizer India
Research & Development
- New Millennium Indian Technology Leadership Initiative
- Indian Council of Medical Research
- Central Research Institute, Kasauli
- Central Drug Research Institute, Lucknow
- Central Council for Research in Unani Medicine
- Central Council for Research in Ayurveda and Siddha
- Central Council for Research in Homeopathy
Traditional Indian Medicines
- Components
- Ayurvedic Supply
Exports
- Summary Pharmaceutical Exports, 1998-2003 (US$000s)
- Exports of Pharmaceuticals, 1999-2003 (US$000s)
- Pharmaceutical Exports by Destination, 2003 (US$000s)
- Balance of Trade in Pharmaceuticals, 1999-2003 (US$000s)
DIRECTORY
- Government Organisations
- Trade Associations
CHARTS
- Pharmaceutical Imports by Type, 1998-2003 (%)
- Percentage Change in Imports by Type, 1999-2003
- Leading Pharmaceutical Suppliers, 2003 (%)
- Cipla Exports by Geographic Area, 2005 (%)
- DRL Sales by Geographic Area, 2005 (%)
- Orchid API Sales by Region, 2005 (%)
- Orchid Formulations Sales by Region, 2005 (%)
- Wockhardt API Sales by Region, 2004 (%)
- Wockhardt Formulations Sales by Region, 2004 (%)
- Pharmaceutical Exports by Type, 1998-2003 (%)
- Pharmaceutical Exports by Destination, 2003 (%)

インドの製薬業界市場レポート

The Pharmaceutical Market: India

Abstract

Market Intelligence Report

Pharmaceutical Market Outlook

Inside the India Market Intelligence Report

Table of Contents